Publications

6444 items matching your search terms.

The histone deacetylase SIRT2 stabilizes Myc oncoproteins

Liu, P. Y.; Xu, N.; Malyukova, A. ; Scarlett, C. J. ; Sun, Y. T. ; Zhang, X. D. ; Ling, D. ; Su, S. P. ; Nelson, C. ; Chang, D. K.; Koach, J. ; Tee, A. E. ; Haber, M. ; Norris, M. D. ; Toon, C. ; Rooman, I. ; Xue, C. ; Cheung, B. B.; Kumar, S. ; Marshall, G. M. ; Biankin, A. V. ; Liu, T.;

CELL DEATH AND DIFFERENTIATION 20 (3) :503-14, 2013

The hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy

Hui, M.; Cazet, A.; Nair, R.; Watkins, D.N.; O'Toole, S.; Swarbrick, A.;

BREAST CANCER RES 15 (2) :203, 2013 10.1186/bcr3401

Purification of molecular machines and nanomotors using phage-derived monoclonal antibody fragments

Esteban, O.; Christ, D.; Stock, D.;

Methods in Molecular Biology 996 :203-17, 2013

Endosomal sorting of GLUT4 and Gap1 is conserved between yeast and insulin-sensitive cells

Shewan, A. M. ; McCann, R. K. ; Lamb, C. A. ; Stirrat, L. ; Kioumourtzoglou, D. ; Adamson, I. S.; Verma, S. James, D. E. Bryant, N. J.;

JOURNAL OF CELL SCIENCE 126 (Pt 7) :1576-82, 2013

Neuroinflammation and neuronal loss precede Abeta plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease

Wright, A..; Raphael Zinna,b, Barbara Hohensinnc, Lyndsey M Konena, Sarah B Beynond, Richard Tana, Andrea Abdipranotoa, Bryce Vissela,b

PLoS One 8 (4) :e59586, 2013 10.1371/journal.pone.0059586

Interleukin-27 signaling promotes immunity against endogenously arising murine tumors

Natividad, K. D.: Junankar, S. R.: Mohd Redzwan, N.: Nair, R.: Wirasinha, R. C.: King, C.: Brink, R.: Swarbrick, A.: Batten, M.:

PLoS One 8 (3) :e57469, 2013 10.1371/journal.pone.0057469

Complex patterns of genomic admixture within Southern Africa

Petersen, D.C.; Libiger, O.; Tindall, E.A.; Hardie, R.; Hannick, L.I.; Glashoff, R.H.; Mukerji, M.; Fernandez, P.; Haacke, W.; Schork, N.J.; Hayes, V. M.;

PLOS GENET 9 (3) :e1003309, 2013 10.1371/journal.pgen.1003309

A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition.

Goff, D. J.; Recart, A. C.; Sadarangani, A.; Chun, H. J.; Barrett, C. L.; Krajewska, M.; Leu, H.; Low-Marchelli, J.; Ma, W.; Shih, A. Y.; Wei, J.; Zhai, D.; Geron, I.; Pu, M.; Bao, L.; Chuang, R.; Balaian, L.; Gotlib, J.; Minden, M.; Martinelli, G.; Rusert, J.; Dao, K. H.; Shazand, K.; Wentworth, P.; Smith, K. M.; Jamieson, C. A.; Morris, S. R.; Messer, K.; Goldstein, L. S.; Hudson, T. J.; Marra, M.; Frazer, K. A.; Pellecchia, M.; Reed, J. C.; Jamieson, C. H.;

Cell Stem Cell 12 (3) :316-28, 2013 10.1016/j.stem.2012.12.011

From the CSIRO preventative health flagship

Molloy, P. ; Samaras, K. ; Muhlhausler, B.; McMillen, C.; Flagship, CSIRO Preventative Hlth;

MEDICAL JOURNAL OF AUSTRALIA 198 (4) :182-182, 2013

Quantitative ultrasound and fracture risk prediction in non-osteoporotic men and women as defined by WHO criteria.

Chan, M.Y.; Nguyen, N.D.; Center, J.R.; Eisman, J.A.; Nguyen, T.V.

OSTEOPOROSIS INTERNATIONAL 24 (3) :1015-22, 2013 10.1007/s00198-012-2001-2

Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma

Yip, P.Y.; Yu, B.; Cooper, W.; Selinger, C.; Ng, C.C.; Kennedy, C.W.; Kohonen-Corish, M.; McCaughan, B.C.; Trent, R.J.; Boyer, M.J.; Kench, J.; Horvath, L.; O'Toole, S.;

Journal of Thoracic Oncology 8 (4) :408-414, 2013 10.1097/JTO.0b013e318283558e

Novel cancer drivers: mining the kinome

Biankin, A. V. ; Grimmond, S. M.;

Genome Medicine 5 (2) :19, 2013

Bariatric surgery for type 2 diabetes: to whom and when?

Samaras, K.;

Minerva Endocrinologica 38 (1) :47-58, 2013

Therapeutic targets in triple negative breast cancer

O'Toole, S.; Beith, M.J.; Millar, E.K.; West, R.; McLean, A.; Cazet, A.; Swarbrick, A.; Oakes, S.R;

JOURNAL OF CLINICAL PATHOLOGY :10.1136/jclinpath-2012-201361, 2013 10.1136/jclinpath-2012-201361

Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1

Caldon, C.E.; Sergio, C.M.; Burgess, A.; Deans, A.J.; Sutherland, R.L.; Musgrove, E.A.;

CELL CYCLE 12 (4) :606-617, 2013 10.4161/cc.23512

Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells

Caldon, C. E.; Sergio, C.M.; Sutherland, R.L.; Musgrove, E.A.;

CELL CYCLE 12 (4) :596-605, 2013 10.4161/cc.23409